Drug & medication recalls High risk

Medisca Inc recalls CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use…

Recall date
February 14, 2014
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0674-2016
FDA classification
Class I
Brand / firm
Medisca Inc
Sold / distributed
Nationwide and Australia

Why it was recalled

Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead.

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use and distribution in prescription compounding, manufacturing, processing, or repackaging only in accordance with FDA regulations and applicable law, Packaged by Medisca Inc. Plattsburgh, NY 12901, USA, NDC #s: 38779-1186-4 (25 g), 38779-1186-5 (100 g), 38779-1186-8 (500 g), 38779-1186-9 (1 kg).

Get recall alerts

Free email alert whenever Medisca Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Medisca Inc